These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18653640)

  • 21. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months.
    Tidjani O; Grunitsky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
    Lancet; 1989 Dec; 2(8676):1357-60. PubMed ID: 2574304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of vaccine efficacy and mortality during routine use of high-titre Edmonston-Zagreb and Schwarz standard measles vaccines in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Markowitz L; Whittle H
    Trans R Soc Trop Med Hyg; 1996; 90(3):326-30. PubMed ID: 8758096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health effects of utilising hospital contacts to provide measles vaccination to children 9-59 months-a randomised controlled trial in Guinea-Bissau.
    Fisker AB; Martins JSD; Jensen AM; Martins C; Aaby P; Thysen SM
    Trials; 2022 Apr; 23(1):349. PubMed ID: 35461287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months.
    Pongrithsukda V; Gluck R; Suwatanapongched S; Kaewmalung P; Muyakul J
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):347-50. PubMed ID: 1818384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
    Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
    Rogers S; Sanders RC; Alpers MP
    J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.
    Whittle H; Hanlon P; O'Neill K; Hanlon L; Marsh V; Jupp E; Aaby P
    Lancet; 1988 Oct; 2(8615):811-4. PubMed ID: 2902264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial.
    Izadi S; Zahraei SM; Salehi M; Mohammadi M; Tabatabaei SM; Mokhtari-Azad T
    Vaccine; 2018 Jan; 36(5):631-636. PubMed ID: 29289382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in the effect of vaccines on the risk of hospitalization due to measles in Guinea-bissau.
    Aaby P; Martins C; Bale C; Garly ML; Rodrigues A; Biai S; Lisse IM; Whittle H; Benn CS
    Pediatr Infect Dis J; 2010 Apr; 29(4):324-8. PubMed ID: 19934785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial.
    Dilraj A; Cutts FT; de Castro JF; Wheeler JG; Brown D; Roth C; Coovadia HM; Bennett JV
    Lancet; 2000 Mar; 355(9206):798-803. PubMed ID: 10711928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization of young infants with Edmonston-Zagreb measles vaccine.
    Markowitz LE; Bernier RH
    Pediatr Infect Dis J; 1987 Sep; 6(9):809-12. PubMed ID: 3313247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.
    Aaby P; Samb B; Simondon F; Seck AM; Knudsen K; Whittle H
    BMJ; 1995 Aug; 311(7003):481-5. PubMed ID: 7647643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months.
    Cutts FT; Othepa O; Vernon AA; Nyandu B; Markowitz LE; Deforest A; Wilkins K; Okwo B
    Int J Epidemiol; 1994 Jun; 23(3):624-31. PubMed ID: 7960392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized Trial of 2 Versus 1 Dose of Measles Vaccine: Effect on Hospital Admission of Children After 9 Months of Age.
    Brønd M; Martins CL; Byberg S; Benn CS; Whittle H; Garly ML; Aaby P; Fisker AB
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):226-233. PubMed ID: 28992261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles incidence, vaccine efficacy, and mortality in two urban African areas with high vaccination coverage.
    Aaby P; Knudsen K; Jensen TG; Thårup J; Poulsen A; Sodemann M; da Silva MC; Whittle H
    J Infect Dis; 1990 Nov; 162(5):1043-8. PubMed ID: 2230232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for measles in young infants in an urban African area with high measles vaccination coverage.
    Balé C; Garly ML; Martins C; Nielsen J; Whittle H; Aaby P
    Pediatr Infect Dis J; 2011 Aug; 30(8):689-93. PubMed ID: 21753261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14-14-2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial.
    Li Y; Chu SY; Yue C; Wannemuehler K; Xie S; Zhang F; Wang Y; Zhang Y; Ma R; Li Y; Zuo Z; Rodewald L; Xiao Q; Feng Z; Wang H; An Z
    Lancet Infect Dis; 2019 Apr; 19(4):402-409. PubMed ID: 30833160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire.
    Cutts FT; Nyandu B; Markowitz LE; Forsey T; Zell ER; Othepa O; Wilkins K
    Vaccine; 1994 Nov; 12(14):1311-6. PubMed ID: 7856296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of early measles vaccination on morbidity and growth: A randomised trial from Guinea-Bissau.
    Steiniche MM; Thysen SM; Jensen AKG; Rodrigues A; Martins C; Meyrowitsch DW; Aaby P; Fisker AB
    Vaccine; 2020 Mar; 38(11):2487-2494. PubMed ID: 32061387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.